Past Earnings Performance
Past criteria checks 0/6
Jiangsu Skyray Instrument's earnings have been declining at an average annual rate of -60.5%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 6.4% per year.
Key information
-60.5%
Earnings growth rate
-60.4%
EPS growth rate
| Industry Growth | 16.0% |
| Revenue growth rate | 6.4% |
| Return on equity | -10.0% |
| Net Margin | -15.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Held Back By Insufficient Growth Even After Shares Climb 30%
Aug 15
Jiangsu Skyray Instrument Co., Ltd. (SZSE:300165) Not Doing Enough For Some Investors As Its Shares Slump 30%
Jun 04Why Investors Shouldn't Be Surprised By Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) 28% Share Price Plunge
Apr 17Returns On Capital At Jiangsu Skyray Instrument (SZSE:300165) Paint A Concerning Picture
Apr 15Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) Business And Shares Still Trailing The Industry
Feb 27Revenue & Expenses Breakdown
How makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|
Quality Earnings: 300165 is currently unprofitable.
Growing Profit Margin: 300165 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300165 is unprofitable, and losses have increased over the past 5 years at a rate of 60.5% per year.
Accelerating Growth: Unable to compare 300165's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300165 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.9%).
Return on Equity
High ROE: 300165 has a negative Return on Equity (-10.04%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y